sever arenavirus caps viral hemorrhage fever sever disease caselaw rate host individual rang limit prophylaxi treatment option new medic countermeasures need virus classify nation institut allergic infect disease said top priority biodefens category pathogen recombin consensus interferon alpha cinα license protein broad clinic appeal howe great therapeutic value until applied hinder short vivo halflif mode frequency administer costly product address limit describe use def replicationdefici adenoviru vector drive express pre postexposur act arenavir infect model hamster entrants h prior challenge pickingé virus pick highly effect protect anim mortal prevent replica liverassoci signifies protect effect still observe single dose given two week also efficacy admins postviru exposure lang attribute control empty protect lethal stable easily elicit long last immune much arena infect technology potent issue may serv broadspectrum antivirus enhance host defense number 